Abstract
The association between use of azathioprine and risk of non-melanoma skin cancer (NMSC) in patients with myasthenia was evaluated in a nationwide setting. Treatment of autoimmune myasthenia frequently involves long-term exposure to immunosuppressants, including azathioprine. Use of azathioprine increases the risk of NMSC in organ recipients and probably also in patients with other autoimmune disorders. No previous study has specifically investigated the risk of NMSC in myasthenia patients treated with azathioprine.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | European journal of neurology : the official journal of the European Federation of Neurological Societies |
| Vol/bind | 21 |
| Udgave nummer | 3 |
| Sider (fra-til) | 454-58 |
| ISSN | 1351-5101 |
| DOI | |
| Status | Udgivet - 2014 |